Drug Type Enzyme |
Synonyms DON/PEG-PGA, Diazo-oxo-L-norleucine/PEG-glutaminase, Diazooxonorleucine/PEG-glutaminase + [3] |
Target |
Action antagonists |
Mechanism NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC6H9N3O3 |
InChIKeyYCWQAMGASJSUIP-YFKPBYRVSA-N |
CAS Registry157-03-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Cell Carcinoma | Phase 2 | Poland | - | |
Renal Cell Carcinoma | Phase 2 | Germany | - | |
Renal Cell Carcinoma | Phase 2 | Poland | - | |
Renal Cell Carcinoma | Phase 2 | Germany | - | |
Stomach Cancer | Phase 2 | Germany | - | |
Stomach Cancer | Phase 2 | Poland | - | |
Stomach Cancer | Phase 2 | Poland | - | |
Stomach Cancer | Phase 2 | - | - | |
Stomach Cancer | Phase 2 | - | - | |
Stomach Cancer | Phase 2 | Germany | - |
Phase 1 | 16 | (nagnsaeqyy) = fggvpioeiw hbuybbraon (bcweomhpub ) | - | 20 May 2011 | |||
Phase 2 | - | (ouivmuxmnk) = fvrgpwgczg wlvmprqyup (errgzzvegm ) View more | - | 20 May 2008 | |||
Phase 1 | - | ljvswnhohb(imvovexyjs) = hxqjhuzzdj gpszgzgiux (prlsbeukri ) View more | - | 20 Jun 2007 | |||
ljvswnhohb(imvovexyjs) = xkunblzdqq gpszgzgiux (prlsbeukri ) |